Adebrelimab Plus Chemoradiotherapy Followed by Adebrelimab Maintenance in Limited-Stage SCLC

NCT07200154 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Limited-stage Small-cell Lung Cancer
Concurrent Chemoradiation Therapy

Interventions

DRUG: Adebrelimab with concurrent chemoradiotherapy

Sponsor

Peking University Cancer Hospital & Institute